Is Metronidazole safe for babies and kids?
Moderate risk for kidsInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Metronidazole poses heightened risk.
What is metronidazole?
The IUPAC name is 2-(2-methyl-5-nitroimidazol-1-yl)ethanol.
Also known as: 2-(2-methyl-5-nitroimidazol-1-yl)ethanol, Metronidazol, 2-Methyl-5-nitroimidazole-1-ethanol, Gineflavir.
- IUPAC name
- 2-(2-methyl-5-nitroimidazol-1-yl)ethanol
- CAS number
- 443-48-1
- Molecular formula
- C6H9N3O3
- Molecular weight
- 171.15 g/mol
- SMILES
- CC1=NC=C(N1CCO)[N+](=O)[O-]
- PubChem CID
- 4173
Risk for babies
Moderate riskInfants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Metronidazole poses heightened risk.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Elevated riskMetronidazole poses pregnancy risk through potential teratogenicity, altered pharmacokinetics (increased blood volume, changed CYP activity), and placental transfer. FDA pregnancy category should be evaluated.
Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.
Regulatory consensus
6 regulatory and scientific bodies have classified Metronidazole. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| IARC | 1987 | Group 2B (possibly carcinogenic to humans) | Classified as Group 2B based on mutagenicity in bacteria (Ames test-positive), carcinogenicity in rodents at high doses (lung adenomas, lymphomas, mammary tumors), and mechanistic evidence as a DNA strand-breaking agent under anaerobic conditions. Epidemiological studies in humans have not demonstrated increased cancer risk at therapeutic doses. Classification predates modern risk assessment approaches. |
| EPA CTX / NTP RoC | — | Reasonably Anticipated to be a Human Carcinogen | |
| EPA CTX / IARC | — | Group 2B - Possibly carcinogenic to humans | |
| EPA CTX / CalEPA | — | Known human carcinogen | |
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 11 positive / 4 negative reports) | |
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 11 positive / 4 negative reports) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter metronidazole
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Metronidazole:
-
Therapeutic alternatives (consult prescriber)
Trade-offs: Drug-specific. Cannot substitute without medical guidance.Relative cost: 1.2-2×
Frequently asked questions
Is metronidazole safe for kids?
Infants have immature drug-metabolizing enzymes (CYP450 ontogeny), reduced renal clearance, and different volume of distribution. Accidental exposure or breast milk transfer of Metronidazole poses heightened risk.
What products contain metronidazole?
Metronidazole appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
What should I do if my child is exposed to metronidazole?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
Why do regulators disagree about metronidazole?
Metronidazole has been classified by 6 agencies including IARC, EPA CTX / NTP RoC, EPA CTX / IARC, EPA CTX / CalEPA, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Metronidazole in the baby app
Look up products containing metronidazole, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (3)
- US FDA: Metronidazole — Approved Indications, IARC 2B Classification Context, Pregnancy Category, Drug Interactions (Alcohol/Disulfiram-Like Reaction), and Neuropathy Risk with Prolonged Use (2020) (2020) — regulatory
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans — Metronidazole: Volume 13 (1977) Initial Evaluation and Supplement 7 (1987) Overall Evaluation — Group 2B, Mutagenicity Data, and Rodent Carcinogenicity Studies (1987) — academic
- ASPCA Animal Poison Control Center: Metronidazole Neurotoxicity in Dogs and Cats — Vestibular Syndrome, Cerebellar Ataxia, Dose Thresholds, Diazepam Adjunct Therapy, and Recovery Prognosis (2021) (2021) — veterinary
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →